AI-assisted, human-published
02/01/2024 /Funding Events
Avation Medical Secures Over $22 Million for Wearable Neuromodulation System
Avation Medical secures over $22 million in its Series C funding round to launch the Vivally System, a groundbreaking wearable neuromodulation device for treating overactive bladder conditions.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com
